Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac245Source: DataRank Database

Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia is a research paper published in Journal of Antimicrobial Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 0.65)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (100)

Marc H. Scheetz ORCID,Helen K. Donnelly ORCID,Alvaro Donayre ORCID,Mengjia Kang ORCID,Estefani Diaz ORCID

Live enrichment

PubMed:35869779 PMC:PMC10205601 OpenAlex:https://openalex.org/W4286697199

NIH

Grant: U19AI135964

NIH

Grant: P01AG049665

NIH

Grant: R56HL135124

NIH

Grant: R01HL153312

NCI NIH HHS

Grant: R50 CA221848

NHLBI NIH HHS

Grant: R01 HL153122

NCATS NIH HHS

Grant: UL1 TR001422

NHLBI NIH HHS

Grant: K08 HL159356

NHLBI NIH HHS

Grant: R01 HL149883

NHLBI NIH HHS

Grant: P01 HL154998

National Institutes of Health

Grant: 1R56HL135124-01

Differential role of tissue-resident and monocyte-derived alveolar macrophages in the development of pulmonary fibrosis

National Institutes of Health

Grant: 5P01AG049665-05

Disordered Proteostasis as a Driver of Disease in the Aging Lung

National Institutes of Health

Grant: 5U19AI135964-02

Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center

Midwestern University

American Association of Colleges of Pharmacy

FWCI

0.65

Citation Percentile

0.7%

Citation Trend

2023

2025

greenLicense: OUP Standard Publication Reuse

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10205601/pdf/dkac245.pdf

publisherhttps://academic.oup.com/jac/article-pdf/77/11/2956/50741145/dkac245.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10205601

journalhttps://doi.org/10.1093/jac/dkac245

Fields of Study

Antibiotics Pharmacokinetics and EfficacyPneumonia and Respiratory InfectionsNosocomial Infections in ICU0301 basic medicine03 medical and health sciencesHumansMeropenemMicrobial Sensitivity TestsAnti-Bacterial AgentsProspective StudiesCritical IllnessIntensive Care UnitsPneumoniaHospitals

MeSH Terms

MeropenemAnti-Bacterial AgentsHospitalsHumansIntensive Care UnitsMicrobial Sensitivity TestsPneumoniaProspective StudiesCritical Illness

Keywords

MeropenemPharmacodynamicsMedicinePneumoniaPharmacokineticsEmergency medicineIntensive care medicineVentilator-associated pneumoniaCross infectionInternal medicineAntibioticsMicrobiologyBiologyAntibiotic resistanceIntensive Care UnitsCritical IllnessHumansMicrobial Sensitivity TestsProspective StudiesHospitalsAnti-Bacterial Agents

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being